You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blastic Plasmacytoid Dendritic Cell Neoplasm

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Yerevan

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    Jul 4, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

    Active, not recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Tagraxofusp-erzs
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 8, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in United States (MB-102, Fludarabine, Cyclophosphamide)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • MB-102
    • +2 more
    • Duarte, California
    • +3 more
    Jul 12, 2022

    Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

    Active, not recruiting
    • Adult Acute Myeloid Leukemia in Remission
    • +12 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

    Recruiting
    • Recurrent Acute Leukemia
    • +16 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Patients Previously Treated WithMustang Bio CAR-T Cell

    Enrolling by invitation
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • +10 more
    • Prior MB-102 CAR-T cell investigational product.
    • Prior MB-106 CAR-T cell investigational product.
    • Duarte, California
    • +4 more
    Dec 8, 2022

    Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Seoul, Gang Nam, Korea, Republic of
        Samsung medical center
      Sep 1, 2020

      Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

      Recruiting
      • Leukemia, Acute Myeloid
      • +7 more
      • Denver, Colorado
      • +4 more
      Aug 29, 2022

      Acute Myeloid Leukemia Trial in Italy (tagraxofusp)

      Recruiting
      • Acute Myeloid Leukemia
      • Bergamo, Italy
      • +7 more
      Dec 17, 2021

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +16 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +4 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Dec 1, 2022

      Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

      Recruiting
      • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 30, 2021

      Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

      Not yet recruiting
      • Acute Leukemia of Ambiguous Lineage
      • +8 more
      • Biospecimen Collection
      • +12 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 22, 2023

      Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

      Completed
      • Acute Myelogenous Leukemia
      • +3 more
      • XmAb14045
      • Jacksonville, Florida
      • +8 more
      Mar 4, 2022

      Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

      Recruiting
      • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • +3 more
      • Gilbert, Arizona
      • +14 more
      Apr 20, 2022

      Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

      Recruiting
      • Acute Biphenotypic Leukemia
      • +11 more
      • Total-Body Irradiation
      • +8 more
      • Los Angeles, California
      • +9 more
      Aug 19, 2022

      Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • TregGraft (Orca-T)
      • Duarte, California
      • +13 more
      Oct 28, 2021

      Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)

      Completed
      • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
      • Acute Myeloid Leukemia
      • Duarte, California
      • +8 more
      Apr 6, 2020

      Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor, Unclassifiable

      Withdrawn
      • Acute Bilineal Leukemia
      • +11 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 12, 2020

      Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Houston (UCART123)

      Terminated
      • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
      • UCART123
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 29, 2019

      Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

      Recruiting
      • Recurrent Histiocytic and Dendritic Cell Neoplasm
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Dec 5, 2022

      Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

      Not yet recruiting
      • Cytomegaloviral Infection
      • Hematopoietic and Lymphoid System Neoplasm
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +2 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Dec 16, 2022

      Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

      Recruiting
      • Hepatocellular Carcinoma
      • +4 more
      • Singapore, Singapore
        National Cancer Center Singapore
      Aug 17, 2022

      Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

      Suspended
      • Hematologic Malignancies
      • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
      • La Jolla, California
        UCSD Medical Center
      Jul 20, 2022